Neural Analytics

Neural Analytics is a Los Angeles-based neurotechnology company focused on transforming bedside brain health assessment through advanced neurodiagnostics. The company developed the Lucid system, an AI-powered transcranial Doppler ultrasound platform designed to automate the monitoring of cerebral blood flow dynamics in a non-invasive, accessible format. Traditionally requiring highly trained sonographers to operate, transcranial Doppler technology has seen limited adoption at scale, and Neural Analytics directly addresses this barrier by embedding artificial intelligence into the workflow. The Lucid system enables clinicians to assess critical conditions such as vasospasm and elevated intracranial pressure without the need for specialized expertise, bringing sophisticated neurological evaluation to the point of care.

Neural Analytics has raised $36 million in Series B funding, reflecting strong investor confidence in its technology and the broader opportunity within the neurodiagnostics market. The company has pursued clinical validation across high-acuity settings, including neurocritical care and emergency medicine, where rapid and accurate brain health assessment can meaningfully influence patient outcomes. Their progress represents a significant step toward standardizing cerebrovascular monitoring in hospital environments that have historically lacked reliable, easy-to-use tools for this purpose. By building regulatory and clinical credibility alongside its product development, Neural Analytics has positioned itself as a serious commercial contender in the neurodiagnostics space.

Neural Analytics matters to the broader neurotech industry because it exemplifies the convergence of artificial intelligence and medical hardware to solve a longstanding clinical challenge. The ability to automate complex neurological assessments at the bedside has far-reaching implications for stroke care, traumatic brain injury management, and post-surgical monitoring. As healthcare systems face growing pressure to deliver specialist-level care with generalist resources, technologies like the Lucid system represent a scalable and cost-effective solution to an unmet need. Neural Analytics is helping to define what the next generation of neurodiagnostic tools looks like, making it a compelling example of how neurotechnology can translate directly into improved patient care.